Ligand Pharmaceuticals Incorporated LGND

301.52 2.48 0.83% as of 25 Sep
Market cap
$6.1B
P/E
30.1×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
756.31 266.19 170.31 211.87 341.11 411.19 1,069.87 773.83 201.66 141.05
Receivables
61.05 42.45 39.31 35.04 91.65 59.06 41.75 55.99 25.60 14.70
Inventory
9.13 14.11 23.97 13.29 27.33 26.49 7.30 7.12 4.37 1.92
Other current assets
5.79 8.81 2.66 2.27 4.67 3.82 4.73 33.60 1.51 2.18
Total current assets
832.27 331.56 237.43 263.60 464.75 500.56 1,123.65 870.54 237.02 163.05
Property, Plant, Equpment (Net)
— 15.13 15.61 12.48 13.19 14.43 7.19 5.37 4.21 1.82
Long-Term Investments
167.95 10.91 49.32 3.00 — — — — 6.44 8.35
Goodwill and Intangible Assets (Total)
326.98 371.90 402.98 458.31 492.47 795.97 325.77 337.90 334.07 302.73
Long Term Assets (Tax, Deferred)
8.35 0.07 0.21 8.53 35.73 24.32 25.61 46.52 84.42 123.89
Long-term assets (Other)
28.21 42.31 9.92 1.74 272.03 4.27 2.27 0.47 4.86 1.74
Total non-current assets
728.37 610.22 549.79 499.07 832.84 861.73 371.27 390.26 434.00 438.53
Total Assets
1,560.64 941.77 787.22 762.67 1,297.59 1,362.29 1,494.92 1,260.80 671.02 601.59
Accounts Payable
3.24 5.23 2.43 5.31 8.40 3.78 2.42 4.18 2.26 2.73
Accrued Expenses
31.45 27.91 12.47 15.68 17.58 18.53 8.58 19.20 7.38 6.40
Current Part of Debt
— — — 76.70 1.00 8.00 1.00 26.43 224.53 212.91
Current Part of Capital Lease
— 0.02 0.01 0.05 0.05 6.59 0.01 — — —
Current Part of Taxes to Pay
1.24 1.20 0.00 — — — — — — —
Current Revenue (Deferred)
— 1.28 1.22 0.36 0.65 29.44 2.14 3.29 — —
Other current liabilities
0.42 1.51 0.26 0.06 13.62 39.88 2.61 29.15 4.70 5.09
Total current liabilities
37.45 37.11 16.78 98.81 41.67 100.11 17.00 82.25 238.87 227.13
Long Term Debt (Total)
446.19 — — 10.00 320.72 442.29 638.96 609.86 18.86 29.56
Non-current Revenue (Deferred)
— 2.25 1.44 0.04 — — — — 4.00 0.00
Long Term Tax Liability (Deferred)
36.02 32.52 31.62 30.62 30.86 64.60 32.94 (47.00) (84.00) (124.00)
Non-current Liabilities (Other)
19.56 33.64 30.70 25.38 80.94 40.12 28.82 7.78 13.51 3.60
Total non-current liabilities
505.98 74.22 69.52 66.37 434.77 552.65 710.68 617.64 32.37 33.17
Total liabilities
543.43 111.34 86.30 165.18 476.43 652.76 727.68 699.89 271.23 260.30
Additional Paid In Capital
400.65 337.38 198.70 147.59 372.97 318.36 367.33 791.11 798.21 769.65
Common Stock (Net)
0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02
Retained Earnings
608.09 498.98 503.02 450.86 449.09 391.95 400.11 (229.20) (400.92) (431.13)
Common Equity (Total)
1,017.21 830.44 700.91 597.49 821.16 709.53 767.23 560.91 399.79 341.29
Shareholders Equity (Total)
1,017.21 830.44 700.91 597.49 821.16 709.53 767.23 560.91 399.79 341.29
Shareholders Equity and Liabilities (Total)
1,560.64 941.77 787.22 762.67 1,297.59 1,362.29 1,494.92 1,260.80 671.02 601.59
Shares (Common)
19.77 19.11 17.56 16.95 16.77 16.08 16.82 20.77 21.15 20.91
Shareholders Equity (Tangible)
690.23 458.54 297.94 139.18 328.68 (86.45) 441.47 223.02 65.72 38.56
Net Debt
(310.12) (266.19) (170.31) (125.17) (19.39) 39.11 (429.91) (137.53) 41.73 101.43
Total Debt
446.19 — — 86.70 321.72 450.29 639.96 636.30 243.39 242.47

Fold the line items

In millions of $ except per-share values · columns are period end dates